← All stocks

ROCKET PHARMACEUTICALS, INC.

RCKT Net selling
CIK 0001281895 #3320 in the set updated 17 Sep 2026
Bought (12 mo)
$34.40K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$978.59K
$0.00 on a plan · $171.84K straight out of an exercise
Sold at will
$806.74K
28 of 29 sales
Net
−$944.19K
−$772.34K against sales at will

By person

21 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Wilson Martin
General Counsel
$334.61K (8)
−$334.61K
598,489
0.5452%
$2.04M
+824.5%
Shah Gaurav
CEO
$285.67K (8) scheduled
−$285.67K
1,056,594
0.9625%
$3.60M
+47.1%
Militello John
See Remarks
$138.26K (9)
−$138.26K
89,780
0.0818%
$305.52K
+74.5%
Stevens Christopher James
Chief Operating Officer
$128.27K (1)
−$128.27K
505,784
0.4607%
$1.72M
Chaudhuri Sarbani
See Remarks
$84.19K (2)
−$84.19K
262,809
0.2394%
$894.34K
+65.0%
Bjork Elisabeth
Director
$34.40K (1)
+$34.40K
50,000
0.0455%
$170.15K
Schwartz Jonathan David
See Remarks
$7.59K (1)
−$7.59K
299,064
0.2724%
$1.02M
+79.1%
RTW INVESTMENTS, LP entity
Director
18,188,457
16.57%
$61.90M
0.0%
Patel Kinnari
See Remarks
468,701
0.4270%
$1.59M
+16.4%
Makker Gotham
Director
415,346
0.3784%
$1.41M
+13.5%
Rizvi Syed Ali-aamir
Chief Medical Officer
407,874
0.3716%
$1.39M
SOUTHWELL DAVID P
Director
204,522
0.1863%
$695.99K
+12,221%
Ondrey Aaron
Chief Financial Officer
128,173
0.1168%
$436.17K
+174.0%
Fong Peter
Director
76,195
0.0694%
$259.29K
WONG RODERICK
Director
75,499
0.0688%
$256.92K
White Mark Andrew
See Remarks
69,140
0.0630%
$235.28K
−4.3%
Dolsten Mikael
Director
67,082
0.0611%
$228.28K
GRANADILLO PEDRO P
Director
54,734
0.0499%
$186.26K
Malik Fady Ibraham
Director
52,862
0.0482%
$179.89K
BOESS CARSTEN
Director
52,862
0.0482%
$179.89K
Pratumsuwan Piratip
Director
30,000
0.0273%
$102.09K
Insider
Date
Role
Action
Shares
Price
Amount
Bjork Elisabeth
2 Jan 2026
Director
Buy
10,000
$3.44
$34.40K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 4,018,862
History held since 29 Sep 2016